SBFM
Sunshine Biopharma Inc
NASDAQ: SBFM · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.96
-0.43% today
Updated 2026-04-30
Market cap
$4.81M
P/E ratio
—
P/S ratio
0.13x
EPS (TTM)
$-1.44
Dividend yield
—
52W range
$1 – $2
Volume
0.0M
Sunshine Biopharma Inc (SBFM) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-16.50%
Operating margin
-19.30%
ROE
-25.70%
ROA
-9.23%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2007 | — | $-13122.00 | — | — | — |
| 2008 | — | $-31105.00 | — | — | — |
| 2009 | — | $-25015.00 | — | — | — |
| 2010 | — | $-537382.00 | — | — | — |
| 2011 | — | $-556202.00 | — | — | — |
| 2012 | — | $-707952.00 | — | — | — |
| 2013 | $0.00 | $-2.49M | — | — | — |
| 2014 | $0.00 | $-1.93M | — | — | — |
| 2015 | $1708.00 | $-1.65M | 100.00% | -45,683.67% | -96,774.47% |
| 2016 | $0.00 | $-3.50M | — | — | — |
| 2017 | $0.00 | $-1.04M | — | — | — |
| 2018 | $447200.00 | $-2.16M | 12.55% | -260.85% | -482.15% |
| 2019 | $21121.00 | $-1.66M | 47.68% | -3,037.91% | -7,860.85% |
| 2020 | $71410.00 | $-2.78M | 63.80% | -807.83% | -3,898.74% |
| 2021 | $228426.00 | $-12.44M | 48.42% | -1,068.24% | -5,444.41% |
| 2022 | $4.35M | $-26.74M | 39.04% | -199.60% | -615.44% |
| 2023 | $24.09M | $-4.51M | 34.61% | -19.86% | -18.70% |
| 2024 | $34.87M | $-5.13M | 30.60% | -16.67% | -14.72% |
| 2025 | $36.31M | $-5.98M | 32.84% | -12.34% | -16.46% |